PKI-587

PF-05212384 · Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PKI-587, covering 2018-11-02 to 2018-11-02. Get the full timeline:

Most recent: Clinical Trial Update: Study of PF-05212384 (Also Known as PKI-587)Administered Intravenously To Subjects With Solid Tumors [Phase 1]